|
 |
|
Innovations that have resulted from close dialogue with customers are the subject of several reports in this issue.
|
|
 |
|
 |
|
BASF will launch a new line of organozinc halide reagents at the OPRD conference, to be held from June 23 through 26 in Montreal, Canada.
|
|
 |
 |
|
 |
|
Strong innovation teams are focusing on special pharma customers' needs and lead the way through BASF's Verbund system.
|
|
 |
Your opinion matters!
Do you like this newsletter? Can we improve it? Please let us know what you think in the Inside Life Sciences News online survey.
|
 |
|
 |
|
BASF will present its chemical intermediates, catalysts and inorganics portfolio at the ChemSpec trade show in Munich, Germany, on June 18 and 19.
|
|
 |
|
 |
|
The 4th BASF Boron Conference will take place in the United States on November 12-13 this year. Highly reputable speakers from academia will join this conference.
|
|
 |
|
 |
|
Chiral intermediates, important components of many pharmaceutical products, are an example of products of, “white biotechnology”, a key technology in the 21st century.
|
|
 |
|
 |
|
A new brochure gives an overview on BASF’s offer related to intermediates especially for the life science industry.
|
|
 |
|
 |
|
BASF introduces a new compound to carry out the synthesis of complex amine containing molecules.
|
|
 |
|
 |
|
Matt Moran, pharmachem expert with the Irish Business and Employers Confederation (IBEC), answered our questions regarding plans and prospects for the future.
|
|
 |
|
 |
|
BASF supports its customers in Great Britain successfully.
|
|
 |
|
 |
|
A remarkable article has been published in „Chimica Oggi“ regarding organozinc reagents.
|
|
 |
|
 |
|
Acid chlorides are very useful as protecting groups as well as building blocks in pharma syntheses.
|
|
 |
|
 |
|
Here is a very special version of this numerical puzzle for you.
|
|
 |
|
|